Holding(s) in Company

/**/

RNS Number : 0314N British Land Co PLC 29 December 2025  

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0001367019

Issuer Name

BRITISH LAND COMPANY PUBLIC LIMITED COMPANY(THE)

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

 

Country of registered office (if applicable)

US



Name

City of registered office

Country of registered office

Morgan Stanley

Wilmington, Delaware

USA



4. Details of the shareholder



Name

City of registered office

Country of registered office

Morgan Stanley & Co. International plc

London

UNITED KINGDOM



5. Date on which the threshold was crossed or reached

23-Dec-2025

6. Date on which Issuer notified

26-Dec-2025

7. Total positions of person(s) subject to the notification obligation



% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.969853

0.273021

6.242874

62417481

Position of previous notification (if applicable)

6.143218

0.254233

6.397451



8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares



Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0001367019



59687764



5.969853

Sub Total 8.A

59687764

5.969853%



8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))



Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Right of recall over securities lending agreements

at any time

at any time

77469

0.007748

Sub Total 8.B1



77469

0.007748%



8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))



Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity Swap

15/03/2027

at any time

Cash

2632992

0.263347

Retail Structured Product - Note

14/10/2030

at any time

Cash

19256

0.001926

Sub Total 8.B2



2652248

0.265273%



9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)



Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Morgan Stanley (Chain 1)







Morgan Stanley (Chain 1)

Morgan Stanley Capital Management, LLC







Morgan Stanley (Chain 1)

Morgan Stanley & Co. LLC







Morgan Stanley (Chain 2)







Morgan Stanley (Chain 2)

Morgan Stanley International Holdings Inc.







Morgan Stanley (Chain 2)

Morgan Stanley International Limited







Morgan Stanley (Chain 2)

Morgan Stanley Investments (UK)







Morgan Stanley (Chain 2)

Morgan Stanley & Co. International plc

5.969853



6.235126%



10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

26-Dec-2025

13. Place Of Completion

Mumbai



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  HOLTLBATMTJTBJA